Hip fracture risk in older US adults by treatment eligibility status based on new National Osteoporosis Foundation guidance

A. C. Looker, B. Dawson-Hughes, A. N A Tosteson, H. Johansson, J. A. Kanis, L. J. Melton

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

Summary: This analysis of National Health and Nutrition Examination Survey III data found a significant risk of incident hip fracture in adults aged 65 years and older who are candidates for treatment to lower fracture risk, according to the new National Osteoporosis Foundation Clinician's Guide. Introduction: The relationship between treatment eligibility by the new National Osteoporosis Foundation (NOF) Guide to the Prevention and Treatment of Osteoporosis and the risk of subsequent hip fracture is unknown. Methods: The study sample consisted of 3,208 men and women ages 65 years and older who were examined in the third National Health and Nutrition Examination Survey (NHANES III, 1988-1994), a nationally representative survey. Risk factors used to define treatment eligibility at baseline were measured in NHANES III or were simulated using World Health Organization study cohorts. Incident hip fractures were ascertained using linked mortality and Medicare records that were obtained for NHANES III participants through December 31, 2000. Cox proportional hazards models were used to estimate the relative risk (RR) of hip fracture by treatment eligibility status. Results: The RR for subsequent hip fracture was 4.9 (95% CI 3.30, 7.94) in treatment-eligible vs treatment-ineligible persons. The increased risk for treatment-eligible persons remained statistically significant when examined by sex or age: RR men=5.5 (2.6, 11.4) and RR women=4.3 (2.2, 8.4); RR 65-79 y=4.8 (2.6, 8.7) and RR 80+ y=4.6 (2.1, 10.1). Conclusions: Treatment-eligible persons were about five times more likely to experience a subsequent hip fracture than the non-eligible persons. The new NOF guidelines appear to predict future hip fracture risk equally in men as in women, and fracture risk prediction did not appear to diminish with age.

Original languageEnglish (US)
Pages (from-to)541-549
Number of pages9
JournalOsteoporosis International
Volume22
Issue number2
DOIs
StatePublished - Feb 2011

Fingerprint

Hip Fractures
Osteoporosis
Nutrition Surveys
Therapeutics
Medicare
Proportional Hazards Models
Cohort Studies
Guidelines

Keywords

  • Incident hip fracture
  • National Osteoporosis Foundation Clinician's Guide
  • Population study
  • Treatment eligibility

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism

Cite this

Looker, A. C., Dawson-Hughes, B., Tosteson, A. N. A., Johansson, H., Kanis, J. A., & Melton, L. J. (2011). Hip fracture risk in older US adults by treatment eligibility status based on new National Osteoporosis Foundation guidance. Osteoporosis International, 22(2), 541-549. https://doi.org/10.1007/s00198-010-1288-0

Hip fracture risk in older US adults by treatment eligibility status based on new National Osteoporosis Foundation guidance. / Looker, A. C.; Dawson-Hughes, B.; Tosteson, A. N A; Johansson, H.; Kanis, J. A.; Melton, L. J.

In: Osteoporosis International, Vol. 22, No. 2, 02.2011, p. 541-549.

Research output: Contribution to journalArticle

Looker, A. C. ; Dawson-Hughes, B. ; Tosteson, A. N A ; Johansson, H. ; Kanis, J. A. ; Melton, L. J. / Hip fracture risk in older US adults by treatment eligibility status based on new National Osteoporosis Foundation guidance. In: Osteoporosis International. 2011 ; Vol. 22, No. 2. pp. 541-549.
@article{0566d5b6e57a48a2b80f34c8d75989a4,
title = "Hip fracture risk in older US adults by treatment eligibility status based on new National Osteoporosis Foundation guidance",
abstract = "Summary: This analysis of National Health and Nutrition Examination Survey III data found a significant risk of incident hip fracture in adults aged 65 years and older who are candidates for treatment to lower fracture risk, according to the new National Osteoporosis Foundation Clinician's Guide. Introduction: The relationship between treatment eligibility by the new National Osteoporosis Foundation (NOF) Guide to the Prevention and Treatment of Osteoporosis and the risk of subsequent hip fracture is unknown. Methods: The study sample consisted of 3,208 men and women ages 65 years and older who were examined in the third National Health and Nutrition Examination Survey (NHANES III, 1988-1994), a nationally representative survey. Risk factors used to define treatment eligibility at baseline were measured in NHANES III or were simulated using World Health Organization study cohorts. Incident hip fractures were ascertained using linked mortality and Medicare records that were obtained for NHANES III participants through December 31, 2000. Cox proportional hazards models were used to estimate the relative risk (RR) of hip fracture by treatment eligibility status. Results: The RR for subsequent hip fracture was 4.9 (95{\%} CI 3.30, 7.94) in treatment-eligible vs treatment-ineligible persons. The increased risk for treatment-eligible persons remained statistically significant when examined by sex or age: RR men=5.5 (2.6, 11.4) and RR women=4.3 (2.2, 8.4); RR 65-79 y=4.8 (2.6, 8.7) and RR 80+ y=4.6 (2.1, 10.1). Conclusions: Treatment-eligible persons were about five times more likely to experience a subsequent hip fracture than the non-eligible persons. The new NOF guidelines appear to predict future hip fracture risk equally in men as in women, and fracture risk prediction did not appear to diminish with age.",
keywords = "Incident hip fracture, National Osteoporosis Foundation Clinician's Guide, Population study, Treatment eligibility",
author = "Looker, {A. C.} and B. Dawson-Hughes and Tosteson, {A. N A} and H. Johansson and Kanis, {J. A.} and Melton, {L. J.}",
year = "2011",
month = "2",
doi = "10.1007/s00198-010-1288-0",
language = "English (US)",
volume = "22",
pages = "541--549",
journal = "Osteoporosis International",
issn = "0937-941X",
publisher = "Springer London",
number = "2",

}

TY - JOUR

T1 - Hip fracture risk in older US adults by treatment eligibility status based on new National Osteoporosis Foundation guidance

AU - Looker, A. C.

AU - Dawson-Hughes, B.

AU - Tosteson, A. N A

AU - Johansson, H.

AU - Kanis, J. A.

AU - Melton, L. J.

PY - 2011/2

Y1 - 2011/2

N2 - Summary: This analysis of National Health and Nutrition Examination Survey III data found a significant risk of incident hip fracture in adults aged 65 years and older who are candidates for treatment to lower fracture risk, according to the new National Osteoporosis Foundation Clinician's Guide. Introduction: The relationship between treatment eligibility by the new National Osteoporosis Foundation (NOF) Guide to the Prevention and Treatment of Osteoporosis and the risk of subsequent hip fracture is unknown. Methods: The study sample consisted of 3,208 men and women ages 65 years and older who were examined in the third National Health and Nutrition Examination Survey (NHANES III, 1988-1994), a nationally representative survey. Risk factors used to define treatment eligibility at baseline were measured in NHANES III or were simulated using World Health Organization study cohorts. Incident hip fractures were ascertained using linked mortality and Medicare records that were obtained for NHANES III participants through December 31, 2000. Cox proportional hazards models were used to estimate the relative risk (RR) of hip fracture by treatment eligibility status. Results: The RR for subsequent hip fracture was 4.9 (95% CI 3.30, 7.94) in treatment-eligible vs treatment-ineligible persons. The increased risk for treatment-eligible persons remained statistically significant when examined by sex or age: RR men=5.5 (2.6, 11.4) and RR women=4.3 (2.2, 8.4); RR 65-79 y=4.8 (2.6, 8.7) and RR 80+ y=4.6 (2.1, 10.1). Conclusions: Treatment-eligible persons were about five times more likely to experience a subsequent hip fracture than the non-eligible persons. The new NOF guidelines appear to predict future hip fracture risk equally in men as in women, and fracture risk prediction did not appear to diminish with age.

AB - Summary: This analysis of National Health and Nutrition Examination Survey III data found a significant risk of incident hip fracture in adults aged 65 years and older who are candidates for treatment to lower fracture risk, according to the new National Osteoporosis Foundation Clinician's Guide. Introduction: The relationship between treatment eligibility by the new National Osteoporosis Foundation (NOF) Guide to the Prevention and Treatment of Osteoporosis and the risk of subsequent hip fracture is unknown. Methods: The study sample consisted of 3,208 men and women ages 65 years and older who were examined in the third National Health and Nutrition Examination Survey (NHANES III, 1988-1994), a nationally representative survey. Risk factors used to define treatment eligibility at baseline were measured in NHANES III or were simulated using World Health Organization study cohorts. Incident hip fractures were ascertained using linked mortality and Medicare records that were obtained for NHANES III participants through December 31, 2000. Cox proportional hazards models were used to estimate the relative risk (RR) of hip fracture by treatment eligibility status. Results: The RR for subsequent hip fracture was 4.9 (95% CI 3.30, 7.94) in treatment-eligible vs treatment-ineligible persons. The increased risk for treatment-eligible persons remained statistically significant when examined by sex or age: RR men=5.5 (2.6, 11.4) and RR women=4.3 (2.2, 8.4); RR 65-79 y=4.8 (2.6, 8.7) and RR 80+ y=4.6 (2.1, 10.1). Conclusions: Treatment-eligible persons were about five times more likely to experience a subsequent hip fracture than the non-eligible persons. The new NOF guidelines appear to predict future hip fracture risk equally in men as in women, and fracture risk prediction did not appear to diminish with age.

KW - Incident hip fracture

KW - National Osteoporosis Foundation Clinician's Guide

KW - Population study

KW - Treatment eligibility

UR - http://www.scopus.com/inward/record.url?scp=78651514080&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=78651514080&partnerID=8YFLogxK

U2 - 10.1007/s00198-010-1288-0

DO - 10.1007/s00198-010-1288-0

M3 - Article

C2 - 20480142

AN - SCOPUS:78651514080

VL - 22

SP - 541

EP - 549

JO - Osteoporosis International

JF - Osteoporosis International

SN - 0937-941X

IS - 2

ER -